nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—atherosclerosis	0.242	1	CbGaD
Alfentanil—ALB—Rosuvastatin—atherosclerosis	0.0545	0.0877	CbGbCtD
Alfentanil—CYP3A7—Simvastatin—atherosclerosis	0.0543	0.0874	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0543	0.0874	CbGbCtD
Alfentanil—CYP3A7—Lovastatin—atherosclerosis	0.0532	0.0855	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0532	0.0855	CbGbCtD
Alfentanil—CYP3A5—Rosuvastatin—atherosclerosis	0.0438	0.0705	CbGbCtD
Alfentanil—CYP3A5—Simvastatin—atherosclerosis	0.0407	0.0655	CbGbCtD
Alfentanil—CYP3A5—Pravastatin—atherosclerosis	0.0399	0.0641	CbGbCtD
Alfentanil—CYP3A5—Lovastatin—atherosclerosis	0.0399	0.0641	CbGbCtD
Alfentanil—ABCB1—Ezetimibe—atherosclerosis	0.0285	0.0459	CbGbCtD
Alfentanil—ABCB1—Simvastatin—atherosclerosis	0.0265	0.0426	CbGbCtD
Alfentanil—ABCB1—Lovastatin—atherosclerosis	0.026	0.0417	CbGbCtD
Alfentanil—ABCB1—Pravastatin—atherosclerosis	0.026	0.0417	CbGbCtD
Alfentanil—CYP3A4—Rosuvastatin—atherosclerosis	0.0171	0.0275	CbGbCtD
Alfentanil—CYP3A4—Ezetimibe—atherosclerosis	0.0171	0.0275	CbGbCtD
Alfentanil—CYP3A4—Simvastatin—atherosclerosis	0.0159	0.0256	CbGbCtD
Alfentanil—CYP3A4—Pravastatin—atherosclerosis	0.0155	0.025	CbGbCtD
Alfentanil—CYP3A4—Lovastatin—atherosclerosis	0.0155	0.025	CbGbCtD
Alfentanil—Laryngospasm—Niacin—atherosclerosis	0.00169	0.0276	CcSEcCtD
Alfentanil—Arrhythmia—Rosuvastatin—atherosclerosis	0.000778	0.0127	CcSEcCtD
Alfentanil—Mental disorder—Rosuvastatin—atherosclerosis	0.000763	0.0125	CcSEcCtD
Alfentanil—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000711	0.0116	CcSEcCtD
Alfentanil—Chills—Lovastatin—atherosclerosis	0.000662	0.0108	CcSEcCtD
Alfentanil—Cough—Rosuvastatin—atherosclerosis	0.000661	0.0108	CcSEcCtD
Alfentanil—Angiopathy—Ezetimibe—atherosclerosis	0.000657	0.0107	CcSEcCtD
Alfentanil—Immune system disorder—Ezetimibe—atherosclerosis	0.000654	0.0107	CcSEcCtD
Alfentanil—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000652	0.0107	CcSEcCtD
Alfentanil—Mental disorder—Ezetimibe—atherosclerosis	0.000634	0.0104	CcSEcCtD
Alfentanil—Erythema—Ezetimibe—atherosclerosis	0.00063	0.0103	CcSEcCtD
Alfentanil—Confusional state—Rosuvastatin—atherosclerosis	0.000624	0.0102	CcSEcCtD
Alfentanil—Chills—Simvastatin—atherosclerosis	0.000619	0.0101	CcSEcCtD
Alfentanil—Visual impairment—Niacin—atherosclerosis	0.000611	0.00998	CcSEcCtD
Alfentanil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000607	0.00992	CcSEcCtD
Alfentanil—Vision blurred—Lovastatin—atherosclerosis	0.000605	0.00989	CcSEcCtD
Alfentanil—Mental disorder—Simvastatin—atherosclerosis	0.000605	0.00988	CcSEcCtD
Alfentanil—Visual impairment—Pravastatin—atherosclerosis	0.000601	0.00983	CcSEcCtD
Alfentanil—Erythema—Simvastatin—atherosclerosis	0.000601	0.00982	CcSEcCtD
Alfentanil—Eye disorder—Niacin—atherosclerosis	0.000592	0.00968	CcSEcCtD
Alfentanil—Cardiac disorder—Pravastatin—atherosclerosis	0.000579	0.00947	CcSEcCtD
Alfentanil—Angiopathy—Niacin—atherosclerosis	0.000575	0.0094	CcSEcCtD
Alfentanil—Chills—Niacin—atherosclerosis	0.000569	0.00929	CcSEcCtD
Alfentanil—Vision blurred—Simvastatin—atherosclerosis	0.000566	0.00926	CcSEcCtD
Alfentanil—Arrhythmia—Niacin—atherosclerosis	0.000566	0.00925	CcSEcCtD
Alfentanil—Chills—Pravastatin—atherosclerosis	0.00056	0.00915	CcSEcCtD
Alfentanil—Arrhythmia—Pravastatin—atherosclerosis	0.000557	0.00911	CcSEcCtD
Alfentanil—Erythema—Niacin—atherosclerosis	0.000552	0.00902	CcSEcCtD
Alfentanil—Cough—Ezetimibe—atherosclerosis	0.00055	0.00899	CcSEcCtD
Alfentanil—Hypertension—Ezetimibe—atherosclerosis	0.000544	0.00889	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000533	0.00871	CcSEcCtD
Alfentanil—Pain—Rosuvastatin—atherosclerosis	0.000529	0.00865	CcSEcCtD
Alfentanil—Confusional state—Lovastatin—atherosclerosis	0.000528	0.00864	CcSEcCtD
Alfentanil—Anaphylactic shock—Lovastatin—atherosclerosis	0.000524	0.00857	CcSEcCtD
Alfentanil—Vision blurred—Niacin—atherosclerosis	0.00052	0.0085	CcSEcCtD
Alfentanil—Confusional state—Ezetimibe—atherosclerosis	0.000518	0.00847	CcSEcCtD
Alfentanil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000514	0.0084	CcSEcCtD
Alfentanil—Vision blurred—Pravastatin—atherosclerosis	0.000512	0.00837	CcSEcCtD
Alfentanil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00051	0.00833	CcSEcCtD
Alfentanil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000504	0.00824	CcSEcCtD
Alfentanil—Skin disorder—Ezetimibe—atherosclerosis	0.000499	0.00816	CcSEcCtD
Alfentanil—Confusional state—Simvastatin—atherosclerosis	0.000494	0.00808	CcSEcCtD
Alfentanil—Urticaria—Rosuvastatin—atherosclerosis	0.000491	0.00803	CcSEcCtD
Alfentanil—Anaphylactic shock—Simvastatin—atherosclerosis	0.00049	0.00802	CcSEcCtD
Alfentanil—Loss of consciousness—Niacin—atherosclerosis	0.000485	0.00793	CcSEcCtD
Alfentanil—Cough—Niacin—atherosclerosis	0.000481	0.00787	CcSEcCtD
Alfentanil—Cough—Pravastatin—atherosclerosis	0.000474	0.00775	CcSEcCtD
Alfentanil—Hypertension—Pravastatin—atherosclerosis	0.000469	0.00767	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000466	0.00762	CcSEcCtD
Alfentanil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000456	0.00745	CcSEcCtD
Alfentanil—Fatigue—Lovastatin—atherosclerosis	0.000452	0.00739	CcSEcCtD
Alfentanil—Anaphylactic shock—Niacin—atherosclerosis	0.00045	0.00736	CcSEcCtD
Alfentanil—Pain—Lovastatin—atherosclerosis	0.000448	0.00733	CcSEcCtD
Alfentanil—Confusional state—Pravastatin—atherosclerosis	0.000447	0.00731	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000444	0.00726	CcSEcCtD
Alfentanil—Asthenia—Rosuvastatin—atherosclerosis	0.000444	0.00725	CcSEcCtD
Alfentanil—Anaphylactic shock—Pravastatin—atherosclerosis	0.000443	0.00725	CcSEcCtD
Alfentanil—Fatigue—Ezetimibe—atherosclerosis	0.000443	0.00725	CcSEcCtD
Alfentanil—Pain—Ezetimibe—atherosclerosis	0.00044	0.00719	CcSEcCtD
Alfentanil—Tachycardia—Niacin—atherosclerosis	0.000439	0.00718	CcSEcCtD
Alfentanil—Pruritus—Rosuvastatin—atherosclerosis	0.000438	0.00715	CcSEcCtD
Alfentanil—Skin disorder—Niacin—atherosclerosis	0.000437	0.00715	CcSEcCtD
Alfentanil—Hyperhidrosis—Niacin—atherosclerosis	0.000435	0.00711	CcSEcCtD
Alfentanil—Feeling abnormal—Lovastatin—atherosclerosis	0.000432	0.00706	CcSEcCtD
Alfentanil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000428	0.00701	CcSEcCtD
Alfentanil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000424	0.00693	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000423	0.00692	CcSEcCtD
Alfentanil—Fatigue—Simvastatin—atherosclerosis	0.000423	0.00691	CcSEcCtD
Alfentanil—Hypotension—Niacin—atherosclerosis	0.000421	0.00688	CcSEcCtD
Alfentanil—Pain—Simvastatin—atherosclerosis	0.000419	0.00685	CcSEcCtD
Alfentanil—Urticaria—Lovastatin—atherosclerosis	0.000416	0.00681	CcSEcCtD
Alfentanil—Body temperature increased—Lovastatin—atherosclerosis	0.000414	0.00677	CcSEcCtD
Alfentanil—Dizziness—Rosuvastatin—atherosclerosis	0.000409	0.00669	CcSEcCtD
Alfentanil—Urticaria—Ezetimibe—atherosclerosis	0.000408	0.00668	CcSEcCtD
Alfentanil—Body temperature increased—Ezetimibe—atherosclerosis	0.000406	0.00664	CcSEcCtD
Alfentanil—Feeling abnormal—Simvastatin—atherosclerosis	0.000404	0.0066	CcSEcCtD
Alfentanil—Somnolence—Niacin—atherosclerosis	0.0004	0.00654	CcSEcCtD
Alfentanil—Rash—Rosuvastatin—atherosclerosis	0.00039	0.00638	CcSEcCtD
Alfentanil—Dermatitis—Rosuvastatin—atherosclerosis	0.00039	0.00637	CcSEcCtD
Alfentanil—Urticaria—Simvastatin—atherosclerosis	0.000389	0.00637	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000389	0.00635	CcSEcCtD
Alfentanil—Body temperature increased—Simvastatin—atherosclerosis	0.000388	0.00634	CcSEcCtD
Alfentanil—Headache—Rosuvastatin—atherosclerosis	0.000387	0.00633	CcSEcCtD
Alfentanil—Hypersensitivity—Lovastatin—atherosclerosis	0.000386	0.00631	CcSEcCtD
Alfentanil—Pain—Niacin—atherosclerosis	0.000385	0.00629	CcSEcCtD
Alfentanil—Fatigue—Pravastatin—atherosclerosis	0.000382	0.00625	CcSEcCtD
Alfentanil—Pain—Pravastatin—atherosclerosis	0.000379	0.0062	CcSEcCtD
Alfentanil—Hypersensitivity—Ezetimibe—atherosclerosis	0.000379	0.00619	CcSEcCtD
Alfentanil—Asthenia—Lovastatin—atherosclerosis	0.000376	0.00615	CcSEcCtD
Alfentanil—Pruritus—Lovastatin—atherosclerosis	0.000371	0.00606	CcSEcCtD
Alfentanil—Asthenia—Ezetimibe—atherosclerosis	0.000369	0.00603	CcSEcCtD
Alfentanil—Nausea—Rosuvastatin—atherosclerosis	0.000367	0.00601	CcSEcCtD
Alfentanil—Feeling abnormal—Pravastatin—atherosclerosis	0.000365	0.00597	CcSEcCtD
Alfentanil—Pruritus—Ezetimibe—atherosclerosis	0.000364	0.00595	CcSEcCtD
Alfentanil—Hypersensitivity—Simvastatin—atherosclerosis	0.000361	0.00591	CcSEcCtD
Alfentanil—Urticaria—Niacin—atherosclerosis	0.000358	0.00585	CcSEcCtD
Alfentanil—Body temperature increased—Niacin—atherosclerosis	0.000356	0.00582	CcSEcCtD
Alfentanil—Urticaria—Pravastatin—atherosclerosis	0.000352	0.00576	CcSEcCtD
Alfentanil—Asthenia—Simvastatin—atherosclerosis	0.000352	0.00575	CcSEcCtD
Alfentanil—Body temperature increased—Pravastatin—atherosclerosis	0.00035	0.00573	CcSEcCtD
Alfentanil—Pruritus—Simvastatin—atherosclerosis	0.000347	0.00567	CcSEcCtD
Alfentanil—Dizziness—Lovastatin—atherosclerosis	0.000347	0.00567	CcSEcCtD
Alfentanil—Dizziness—Ezetimibe—atherosclerosis	0.00034	0.00556	CcSEcCtD
Alfentanil—Vomiting—Lovastatin—atherosclerosis	0.000333	0.00545	CcSEcCtD
Alfentanil—Hypersensitivity—Niacin—atherosclerosis	0.000332	0.00542	CcSEcCtD
Alfentanil—Rash—Lovastatin—atherosclerosis	0.00033	0.0054	CcSEcCtD
Alfentanil—Dermatitis—Lovastatin—atherosclerosis	0.00033	0.0054	CcSEcCtD
Alfentanil—Headache—Lovastatin—atherosclerosis	0.000328	0.00537	CcSEcCtD
Alfentanil—Vomiting—Ezetimibe—atherosclerosis	0.000327	0.00534	CcSEcCtD
Alfentanil—Hypersensitivity—Pravastatin—atherosclerosis	0.000327	0.00534	CcSEcCtD
Alfentanil—Dizziness—Simvastatin—atherosclerosis	0.000324	0.0053	CcSEcCtD
Alfentanil—Rash—Ezetimibe—atherosclerosis	0.000324	0.0053	CcSEcCtD
Alfentanil—Dermatitis—Ezetimibe—atherosclerosis	0.000324	0.00529	CcSEcCtD
Alfentanil—Asthenia—Niacin—atherosclerosis	0.000323	0.00528	CcSEcCtD
Alfentanil—Headache—Ezetimibe—atherosclerosis	0.000322	0.00527	CcSEcCtD
Alfentanil—Pruritus—Niacin—atherosclerosis	0.000318	0.00521	CcSEcCtD
Alfentanil—Asthenia—Pravastatin—atherosclerosis	0.000318	0.0052	CcSEcCtD
Alfentanil—Pruritus—Pravastatin—atherosclerosis	0.000314	0.00513	CcSEcCtD
Alfentanil—Vomiting—Simvastatin—atherosclerosis	0.000312	0.0051	CcSEcCtD
Alfentanil—Nausea—Lovastatin—atherosclerosis	0.000311	0.00509	CcSEcCtD
Alfentanil—Rash—Simvastatin—atherosclerosis	0.000309	0.00505	CcSEcCtD
Alfentanil—Dermatitis—Simvastatin—atherosclerosis	0.000309	0.00505	CcSEcCtD
Alfentanil—Headache—Simvastatin—atherosclerosis	0.000307	0.00502	CcSEcCtD
Alfentanil—Nausea—Ezetimibe—atherosclerosis	0.000305	0.00499	CcSEcCtD
Alfentanil—Dizziness—Niacin—atherosclerosis	0.000298	0.00487	CcSEcCtD
Alfentanil—Dizziness—Pravastatin—atherosclerosis	0.000293	0.00479	CcSEcCtD
Alfentanil—Nausea—Simvastatin—atherosclerosis	0.000291	0.00476	CcSEcCtD
Alfentanil—Vomiting—Niacin—atherosclerosis	0.000286	0.00468	CcSEcCtD
Alfentanil—Rash—Niacin—atherosclerosis	0.000284	0.00464	CcSEcCtD
Alfentanil—Dermatitis—Niacin—atherosclerosis	0.000284	0.00464	CcSEcCtD
Alfentanil—Headache—Niacin—atherosclerosis	0.000282	0.00461	CcSEcCtD
Alfentanil—Vomiting—Pravastatin—atherosclerosis	0.000282	0.00461	CcSEcCtD
Alfentanil—Rash—Pravastatin—atherosclerosis	0.000279	0.00457	CcSEcCtD
Alfentanil—Dermatitis—Pravastatin—atherosclerosis	0.000279	0.00456	CcSEcCtD
Alfentanil—Headache—Pravastatin—atherosclerosis	0.000278	0.00454	CcSEcCtD
Alfentanil—Nausea—Niacin—atherosclerosis	0.000267	0.00437	CcSEcCtD
Alfentanil—Nausea—Pravastatin—atherosclerosis	0.000263	0.0043	CcSEcCtD
Alfentanil—ALB—Metabolism—ALOX5AP—atherosclerosis	1.85e-05	0.000246	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALOX15—atherosclerosis	1.85e-05	0.000246	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.85e-05	0.000246	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PDGFB—atherosclerosis	1.85e-05	0.000246	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLTP—atherosclerosis	1.83e-05	0.000244	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MMP1—atherosclerosis	1.83e-05	0.000243	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCG5—atherosclerosis	1.83e-05	0.000243	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.82e-05	0.000243	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.82e-05	0.000243	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.82e-05	0.000243	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—F2—atherosclerosis	1.79e-05	0.000238	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LPA—atherosclerosis	1.76e-05	0.000235	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CAV1—atherosclerosis	1.75e-05	0.000233	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.75e-05	0.000233	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.75e-05	0.000233	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.75e-05	0.000233	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—APOA1—atherosclerosis	1.75e-05	0.000233	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.72e-05	0.000229	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	1.71e-05	0.000228	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.71e-05	0.000227	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BGN—atherosclerosis	1.71e-05	0.000227	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.7e-05	0.000226	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.69e-05	0.000226	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOA5—atherosclerosis	1.69e-05	0.000225	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.67e-05	0.000223	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.67e-05	0.000223	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—F2—atherosclerosis	1.67e-05	0.000222	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—atherosclerosis	1.65e-05	0.000219	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.64e-05	0.000219	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.64e-05	0.000218	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KNG1—atherosclerosis	1.63e-05	0.000217	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PLA2G1B—atherosclerosis	1.63e-05	0.000217	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LIPC—atherosclerosis	1.63e-05	0.000216	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	1.62e-05	0.000216	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALOX15—atherosclerosis	1.62e-05	0.000216	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.62e-05	0.000216	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA2—atherosclerosis	1.62e-05	0.000216	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.62e-05	0.000216	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOC3—atherosclerosis	1.62e-05	0.000215	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.61e-05	0.000215	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.61e-05	0.000214	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LDLR—atherosclerosis	1.61e-05	0.000214	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCG5—atherosclerosis	1.6e-05	0.000213	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CG—atherosclerosis	1.59e-05	0.000212	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.59e-05	0.000212	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	1.59e-05	0.000212	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.59e-05	0.000212	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.59e-05	0.000211	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.59e-05	0.000211	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PLG—atherosclerosis	1.58e-05	0.000211	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALOX5—atherosclerosis	1.57e-05	0.000209	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CETP—atherosclerosis	1.57e-05	0.000209	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.56e-05	0.000208	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LPA—atherosclerosis	1.54e-05	0.000206	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.51e-05	0.000201	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.5e-05	0.0002	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.5e-05	0.0002	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	1.5e-05	0.000199	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BGN—atherosclerosis	1.5e-05	0.000199	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA5—atherosclerosis	1.48e-05	0.000197	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IGF1—atherosclerosis	1.46e-05	0.000194	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.45e-05	0.000193	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP3—atherosclerosis	1.45e-05	0.000193	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF2—atherosclerosis	1.44e-05	0.000192	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOB—atherosclerosis	1.44e-05	0.000191	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.43e-05	0.00019	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.42e-05	0.000189	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.41e-05	0.000188	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NAMPT—atherosclerosis	1.41e-05	0.000188	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.4e-05	0.000187	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LIPC—atherosclerosis	1.4e-05	0.000186	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.4e-05	0.000186	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOB—atherosclerosis	1.4e-05	0.000186	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOC3—atherosclerosis	1.39e-05	0.000185	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINE1—atherosclerosis	1.39e-05	0.000185	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.39e-05	0.000185	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LDLR—atherosclerosis	1.38e-05	0.000184	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALOX5—atherosclerosis	1.38e-05	0.000183	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EDN1—atherosclerosis	1.38e-05	0.000183	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—LPL—atherosclerosis	1.37e-05	0.000183	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL5—atherosclerosis	1.36e-05	0.000182	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CETP—atherosclerosis	1.35e-05	0.00018	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GPX1—atherosclerosis	1.34e-05	0.000178	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LPL—atherosclerosis	1.33e-05	0.000178	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.32e-05	0.000176	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS3—atherosclerosis	1.32e-05	0.000176	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CD36—atherosclerosis	1.3e-05	0.000174	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	1.3e-05	0.000173	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SCARB1—atherosclerosis	1.29e-05	0.000172	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.26e-05	0.000167	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.24e-05	0.000165	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NAMPT—atherosclerosis	1.23e-05	0.000164	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LIPC—atherosclerosis	1.23e-05	0.000163	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMGCR—atherosclerosis	1.22e-05	0.000163	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOC3—atherosclerosis	1.22e-05	0.000162	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARA—atherosclerosis	1.21e-05	0.000161	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LDLR—atherosclerosis	1.21e-05	0.000161	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CETP—atherosclerosis	1.18e-05	0.000158	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FABP4—atherosclerosis	1.18e-05	0.000157	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LCAT—atherosclerosis	1.18e-05	0.000157	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.18e-05	0.000157	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AGT—atherosclerosis	1.17e-05	0.000156	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.17e-05	0.000156	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.16e-05	0.000155	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA4—atherosclerosis	1.16e-05	0.000154	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOE—atherosclerosis	1.15e-05	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.14e-05	0.000152	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAV1—atherosclerosis	1.14e-05	0.000152	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.14e-05	0.000152	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOA1—atherosclerosis	1.14e-05	0.000151	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SCARB1—atherosclerosis	1.13e-05	0.000151	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.12e-05	0.000149	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.12e-05	0.000149	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.11e-05	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.11e-05	0.000147	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.1e-05	0.000147	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCA1—atherosclerosis	1.09e-05	0.000145	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.08e-05	0.000144	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMGCR—atherosclerosis	1.07e-05	0.000143	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.07e-05	0.000142	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—F2—atherosclerosis	1.05e-05	0.00014	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.05e-05	0.00014	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.05e-05	0.00014	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOB—atherosclerosis	1.04e-05	0.000138	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.04e-05	0.000138	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000135	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.01e-05	0.000134	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—atherosclerosis	1e-05	0.000133	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.97e-06	0.000133	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.97e-06	0.000133	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.97e-06	0.000133	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA2—atherosclerosis	9.97e-06	0.000133	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LPL—atherosclerosis	9.92e-06	0.000132	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.85e-06	0.000131	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—INS—atherosclerosis	9.83e-06	0.000131	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GPX1—atherosclerosis	9.68e-06	0.000129	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	9.67e-06	0.000129	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—INS—atherosclerosis	9.56e-06	0.000127	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCA1—atherosclerosis	9.54e-06	0.000127	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—atherosclerosis	9.54e-06	0.000127	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPA—atherosclerosis	9.52e-06	0.000127	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CD36—atherosclerosis	9.43e-06	0.000126	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL2—atherosclerosis	9.4e-06	0.000125	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—atherosclerosis	9.34e-06	0.000124	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1—atherosclerosis	9.24e-06	0.000123	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BGN—atherosclerosis	9.22e-06	0.000123	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA5—atherosclerosis	9.12e-06	0.000121	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK3—atherosclerosis	9.02e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—atherosclerosis	9.01e-06	0.00012	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOB—atherosclerosis	8.95e-06	0.000119	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—atherosclerosis	8.93e-06	0.000119	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.78e-06	0.000117	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	8.78e-06	0.000117	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARA—atherosclerosis	8.76e-06	0.000117	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—atherosclerosis	8.75e-06	0.000117	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—atherosclerosis	8.71e-06	0.000116	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—atherosclerosis	8.62e-06	0.000115	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LPL—atherosclerosis	8.55e-06	0.000114	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AGT—atherosclerosis	8.49e-06	0.000113	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.48e-06	0.000113	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—atherosclerosis	8.38e-06	0.000112	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GPX1—atherosclerosis	8.34e-06	0.000111	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOE—atherosclerosis	8.32e-06	0.000111	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAV1—atherosclerosis	8.24e-06	0.00011	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOA1—atherosclerosis	8.22e-06	0.000109	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—atherosclerosis	8.19e-06	0.000109	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CD36—atherosclerosis	8.12e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—atherosclerosis	7.88e-06	0.000105	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOB—atherosclerosis	7.84e-06	0.000104	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—atherosclerosis	7.69e-06	0.000102	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—atherosclerosis	7.63e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.61e-06	0.000101	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LIPC—atherosclerosis	7.56e-06	0.000101	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARA—atherosclerosis	7.55e-06	0.000101	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOC3—atherosclerosis	7.51e-06	0.0001	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.51e-06	9.99e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LPL—atherosclerosis	7.49e-06	9.97e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LDLR—atherosclerosis	7.47e-06	9.94e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	7.43e-06	9.9e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AGT—atherosclerosis	7.31e-06	9.73e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPX1—atherosclerosis	7.3e-06	9.73e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CETP—atherosclerosis	7.29e-06	9.71e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—atherosclerosis	7.24e-06	9.65e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	7.18e-06	9.56e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOE—atherosclerosis	7.16e-06	9.54e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CD36—atherosclerosis	7.11e-06	9.47e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—INS—atherosclerosis	7.11e-06	9.46e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAV1—atherosclerosis	7.1e-06	9.45e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOA1—atherosclerosis	7.08e-06	9.43e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—atherosclerosis	7.07e-06	9.41e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.98e-06	9.3e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—atherosclerosis	6.74e-06	8.98e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—atherosclerosis	6.72e-06	8.95e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	6.65e-06	8.86e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARA—atherosclerosis	6.61e-06	8.81e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.6e-06	8.78e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	6.54e-06	8.71e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	6.52e-06	8.68e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—atherosclerosis	6.51e-06	8.67e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—atherosclerosis	6.46e-06	8.61e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AGT—atherosclerosis	6.41e-06	8.53e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOE—atherosclerosis	6.28e-06	8.36e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—atherosclerosis	6.24e-06	8.31e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—atherosclerosis	6.23e-06	8.3e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAV1—atherosclerosis	6.22e-06	8.28e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA1—atherosclerosis	6.2e-06	8.26e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—INS—atherosclerosis	6.12e-06	8.15e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—atherosclerosis	6.08e-06	8.1e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	6.04e-06	8.04e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—atherosclerosis	5.98e-06	7.96e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.88e-06	7.83e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	5.71e-06	7.6e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.7e-06	7.59e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.66e-06	7.54e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	5.54e-06	7.38e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—atherosclerosis	5.47e-06	7.28e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—atherosclerosis	5.37e-06	7.14e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—INS—atherosclerosis	5.36e-06	7.14e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.04e-06	6.72e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—atherosclerosis	4.92e-06	6.54e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—atherosclerosis	4.91e-06	6.53e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOB—atherosclerosis	4.83e-06	6.43e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—atherosclerosis	4.7e-06	6.26e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.7e-06	6.26e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPL—atherosclerosis	4.61e-06	6.14e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPX1—atherosclerosis	4.5e-06	5.99e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CD36—atherosclerosis	4.38e-06	5.84e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—atherosclerosis	4.3e-06	5.73e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—atherosclerosis	4.18e-06	5.56e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.15e-06	5.53e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARA—atherosclerosis	4.07e-06	5.43e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—atherosclerosis	3.96e-06	5.28e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AGT—atherosclerosis	3.95e-06	5.25e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOE—atherosclerosis	3.87e-06	5.15e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—atherosclerosis	3.85e-06	5.13e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAV1—atherosclerosis	3.83e-06	5.1e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA1—atherosclerosis	3.82e-06	5.09e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.49e-06	4.65e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—atherosclerosis	3.37e-06	4.48e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—INS—atherosclerosis	3.3e-06	4.4e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—atherosclerosis	3.03e-06	4.03e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—atherosclerosis	2.9e-06	3.86e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—atherosclerosis	2.86e-06	3.81e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.65e-06	3.53e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—atherosclerosis	2.47e-06	3.28e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—atherosclerosis	2.16e-06	2.88e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—atherosclerosis	1.33e-06	1.77e-05	CbGpPWpGaD
